Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP   US8649091068

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/24/2014 07/25/2014 07/28/2014 07/29/2014 07/30/2014 Date
6.25(c) 6.17(c) 6.06(c) 6.08(c) 6.16(c) Last
65 877 68 145 91 530 52 027 49 377 Volume
-0.32% -1.28% -1.78% +0.33% +1.32% Change
More quotes
Company
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company which engages in research, discovery, development and commercialization of proprietary drugs based on prostones and other novel drug technologies. Prostones are naturally occurring fatty acid metabolites with unique physiological... 
Surperformance© rating of Sucampo Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 101 M
EBIT 2014 16,0 M
Net income 2014 5,00 M
Finance 2014 12,8 M
Yield 2014 -
Sales 2015 124 M
EBIT 2015 39,8 M
Net income 2015 31,5 M
Finance 2015 35,7 M
Yield 2015 -
PER 2014 31,92
PER 2015 12,62
EV / Sales 2014 2,58x
EV / Sales 2015 1,91x
Capitalization 273 M
More Financials
Latest news on SUCAMPO PHARMACEUTICALS, I
07/23 SUCAMPO PHARMACEUTICALS : Announces Publication of NICE Recommendation for AMITI..
07/22 SUCAMPO PHARMACEUTICALS : Other Events (form 8-K)
07/22 SUCAMPO PHARMACEUTICALS : Announces Second Quarter 2014 Financial Results and Co..
07/07 SUCAMPO PHARMACEUTICALS : Swissmedic Approves AMITIZA(R) (Lubiprostone) for the ..
06/17 SUCAMPO PHARMACEUTICALS : AMITIZA(R) (Lubiprostone) Receives NICE Recommendation
06/12 SUCAMPO PHARMACEUTICALS : Issues Statement Regarding Anesthetic and Analgesic Dr..
06/05 SUCAMPO PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exh..
05/29 SUCAMPO PHARMACEUTICALS : Other Events (form 8-K)
05/29 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at 2014 Jefferie..
05/19 SUCAMPO PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exh..
05/16 SUCAMPO PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders (f..
05/13 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the 2014 UBS ..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
Sucampo Pharmaceuticals, I : Income Statement Evolution
More Financials
EPS Revisions
Sucampo Pharmaceuticals, I : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF